Kevin Núño
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kevin Núño has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Emre Dikici
Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, USA
2 shared publicationsSapna Deo
Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, USA
2 shared publications- Sylvia Daunert
Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, USA
2 shared publications Anne Sophie Jensen
Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA
1 shared publicationEleonore Beurel
Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, USA
1 shared publicationGregory O'COnnor
Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA; Dr. JT Macdonald Biomedical Nanotechnology Institute (BioNIUM), University of Miami, Miami, FL, 33136, USA
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1754
Cannabidiol and Epigenetic Regulation of Hair Follicle Cycling: Receptor Crosstalk and Transcriptional Control in Alopecia
Cannabidiol (CBD) is a non-intoxicating phytocannabinoid with increasingly recognized effects on cutaneous and hair follicle (HF) biology. This narrative review evaluates CBD-responsive signaling and its intersection with transcriptional, epigenetic, and post-transcriptional mechanisms relevant to HF cycling and alopecia, with particular emphasis on the hierarchy of experimental evidence. Available data indicate that CBD does not exert a uniformly pro-growth effect, but instead produces concentration-, compartment-, and context-dependent responses. In human HFs, submicromolar CBD primarily demonstrates anti-inflammatory activity, whereas micromolar exposure suppresses hair shaft production and promotes catagen through TRPV4-dependent Ca2+ signaling. CBD also modulates adenosine and Wnt/β-catenin pathways and can restore β-catenin expression in human dermal papilla cells under inhibitory conditions. Beyond acute receptor signaling, CBD influences DNA methylation, histone modifications, miRNA networks, and transcriptional regulators including PPARγ and AhR. However, most of this evidence derives from non-follicular systems, and direct CBD-induced epigenetic remodeling of human HFs has not been demonstrated. Among alopecia subtypes, AGA has the strongest mechanistic and preliminary clinical rationale, whereas evidence in AA and scarring alopecia remains largely indirect. Translation is further limited by uncertain intrafollicular CBD exposure, formulation-dependent delivery, and the absence of controlled clinical efficacy data. CBD should therefore be viewed as a context-dependent regulator of follicular signaling rather than an established hair growth treatment. Future studies should define follicular pharmacokinetics, establish concentration–response relationships, and test pathway causality in intact human HFs and disease-specific models.
- 5 November 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1754
Open AccessCannabidiol and Epigenetic Regulation of Hair Follicle Cycling: Receptor Crosstalk and Transcriptional Control in Alopecia
Cannabidiol (CBD) is a non-intoxicating phytocannabinoid with increasingly recognized effects on cutaneous and hair follicle (HF) biology. This narrative review evaluates CBD-responsive signaling and its intersection with transcriptional, epigenetic, and post-transcriptional mechanisms relevant to HF cycling and alopecia, with particular emphasis on the hierarchy of experimental evidence. Available data indicate that CBD does not exert a uniformly pro-growth effect, but instead produces concentration-, compartment-, and context-dependent responses. In human HFs, submicromolar CBD primarily demonstrates anti-inflammatory activity, whereas micromolar exposure suppresses hair shaft production and promotes catagen through TRPV4-dependent Ca2+ signaling. CBD also modulates adenosine and Wnt/β-catenin pathways and can restore β-catenin expression in human dermal papilla cells under inhibitory conditions. Beyond acute receptor signaling, CBD influences DNA methylation, histone modifications, miRNA networks, and transcriptional regulators including PPARγ and AhR. However, most of this evidence derives from non-follicular systems, and direct CBD-induced epigenetic remodeling of human HFs has not been demonstrated. Among alopecia subtypes, AGA has the strongest mechanistic and preliminary clinical rationale, whereas evidence in AA and scarring alopecia remains largely indirect. Translation is further limited by uncertain intrafollicular CBD exposure, formulation-dependent delivery, and the absence of controlled clinical efficacy data. CBD should therefore be viewed as a context-dependent regulator of follicular signaling rather than an established hair growth treatment. Future studies should define follicular pharmacokinetics, establish concentration–response relationships, and test pathway causality in intact human HFs and disease-specific models.
- Open Access
- 28 December 2025
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 12 (1)
DPO production by gut commensals suggests a broader role in bacterial communication and host-microbiome interactions
The quorum-sensing molecule 3,5-dimethylpyrazine-2-ol (DPO), known for regulating biofilm formation in Vibrio cholerae, has unknown distribution among commensal bacteria. We screened 37 bacterial strains using a validated biosensor and found widespread production. Inoculating mice with high producers elevated gut DPO levels, highlighting DPO’s potential influence on gut microbiota. These findings expand DPO’s ecological relevance and underscore quorum sensing as a potentially critical influence on microbiome function and host-microbe interactions.
- 28 December 2025
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 12 (1)
Open AccessDPO production by gut commensals suggests a broader role in bacterial communication and host-microbiome interactions
The quorum-sensing molecule 3,5-dimethylpyrazine-2-ol (DPO), known for regulating biofilm formation in Vibrio cholerae, has unknown distribution among commensal bacteria. We screened 37 bacterial strains using a validated biosensor and found widespread production. Inoculating mice with high producers elevated gut DPO levels, highlighting DPO’s potential influence on gut microbiota. These findings expand DPO’s ecological relevance and underscore quorum sensing as a potentially critical influence on microbiome function and host-microbe interactions.
- 9 September 2024
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 100, 101304
Insights into Women's health: Exploring the vaginal microbiome, quorum sensing dynamics, and therapeutic potential of quorum sensing quenchers
- 9 September 2024
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 100, 101304
Insights into Women's health: Exploring the vaginal microbiome, quorum sensing dynamics, and therapeutic potential of quorum sensing quenchers